nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Pimecrolimus—atopic dermatitis	0.12	0.258	CbGbCtD
Lurasidone—CYP3A4—Tacrolimus—atopic dermatitis	0.0712	0.153	CbGbCtD
Lurasidone—CYP3A4—Loratadine—atopic dermatitis	0.0521	0.112	CbGbCtD
Lurasidone—CYP3A4—Methylprednisolone—atopic dermatitis	0.0476	0.103	CbGbCtD
Lurasidone—CYP3A4—Triamcinolone—atopic dermatitis	0.0361	0.0778	CbGbCtD
Lurasidone—CYP3A4—Betamethasone—atopic dermatitis	0.031	0.0668	CbGbCtD
Lurasidone—CYP3A4—Prednisolone—atopic dermatitis	0.0306	0.0659	CbGbCtD
Lurasidone—CYP3A4—Hydrocortisone—atopic dermatitis	0.029	0.0624	CbGbCtD
Lurasidone—CYP3A4—Prednisone—atopic dermatitis	0.0289	0.0622	CbGbCtD
Lurasidone—CYP3A4—Dexamethasone—atopic dermatitis	0.018	0.0388	CbGbCtD
Lurasidone—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000557	0.0012	CcSEcCtD
Lurasidone—Eye disorder—Hydrocortisone—atopic dermatitis	0.000552	0.00119	CcSEcCtD
Lurasidone—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00055	0.00118	CcSEcCtD
Lurasidone—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000545	0.00117	CcSEcCtD
Lurasidone—Arrhythmia—Prednisolone—atopic dermatitis	0.00054	0.00116	CcSEcCtD
Lurasidone—Vomiting—Mometasone—atopic dermatitis	0.000537	0.00116	CcSEcCtD
Lurasidone—Rash—Mometasone—atopic dermatitis	0.000533	0.00115	CcSEcCtD
Lurasidone—Dermatitis—Mometasone—atopic dermatitis	0.000532	0.00114	CcSEcCtD
Lurasidone—Abdominal pain—Tacrolimus—atopic dermatitis	0.000532	0.00114	CcSEcCtD
Lurasidone—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000527	0.00113	CcSEcCtD
Lurasidone—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000526	0.00113	CcSEcCtD
Lurasidone—Eye disorder—Methylprednisolone—atopic dermatitis	0.000518	0.00111	CcSEcCtD
Lurasidone—Mental disorder—Hydrocortisone—atopic dermatitis	0.000517	0.00111	CcSEcCtD
Lurasidone—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000515	0.00111	CcSEcCtD
Lurasidone—Malnutrition—Hydrocortisone—atopic dermatitis	0.000514	0.00111	CcSEcCtD
Lurasidone—Bradycardia—Betamethasone—atopic dermatitis	0.000513	0.0011	CcSEcCtD
Lurasidone—Bradycardia—Dexamethasone—atopic dermatitis	0.000513	0.0011	CcSEcCtD
Lurasidone—Neutropenia—Prednisone—atopic dermatitis	0.000513	0.0011	CcSEcCtD
Lurasidone—Erectile dysfunction—Prednisone—atopic dermatitis	0.000505	0.00109	CcSEcCtD
Lurasidone—Angiopathy—Methylprednisolone—atopic dermatitis	0.000503	0.00108	CcSEcCtD
Lurasidone—Nausea—Mometasone—atopic dermatitis	0.000502	0.00108	CcSEcCtD
Lurasidone—Weight increased—Prednisone—atopic dermatitis	0.000499	0.00107	CcSEcCtD
Lurasidone—Arrhythmia—Triamcinolone—atopic dermatitis	0.000497	0.00107	CcSEcCtD
Lurasidone—Vision blurred—Prednisolone—atopic dermatitis	0.000496	0.00107	CcSEcCtD
Lurasidone—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000496	0.00107	CcSEcCtD
Lurasidone—Hyperglycaemia—Prednisone—atopic dermatitis	0.000495	0.00106	CcSEcCtD
Lurasidone—Mental disorder—Methylprednisolone—atopic dermatitis	0.000486	0.00105	CcSEcCtD
Lurasidone—Malnutrition—Methylprednisolone—atopic dermatitis	0.000483	0.00104	CcSEcCtD
Lurasidone—Asthenia—Tacrolimus—atopic dermatitis	0.000482	0.00104	CcSEcCtD
Lurasidone—Angioedema—Prednisolone—atopic dermatitis	0.000481	0.00103	CcSEcCtD
Lurasidone—Pruritus—Tacrolimus—atopic dermatitis	0.000476	0.00102	CcSEcCtD
Lurasidone—Malaise—Prednisolone—atopic dermatitis	0.000475	0.00102	CcSEcCtD
Lurasidone—Vertigo—Prednisolone—atopic dermatitis	0.000473	0.00102	CcSEcCtD
Lurasidone—Syncope—Prednisolone—atopic dermatitis	0.000472	0.00101	CcSEcCtD
Lurasidone—Eye disorder—Dexamethasone—atopic dermatitis	0.000471	0.00101	CcSEcCtD
Lurasidone—Eye disorder—Betamethasone—atopic dermatitis	0.000471	0.00101	CcSEcCtD
Lurasidone—Angioedema—Hydrocortisone—atopic dermatitis	0.00047	0.00101	CcSEcCtD
Lurasidone—Back pain—Triamcinolone—atopic dermatitis	0.000468	0.00101	CcSEcCtD
Lurasidone—Malaise—Hydrocortisone—atopic dermatitis	0.000463	0.000997	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisolone—atopic dermatitis	0.000463	0.000995	CcSEcCtD
Lurasidone—Vertigo—Hydrocortisone—atopic dermatitis	0.000462	0.000993	CcSEcCtD
Lurasidone—Syncope—Hydrocortisone—atopic dermatitis	0.000461	0.000991	CcSEcCtD
Lurasidone—Diarrhoea—Tacrolimus—atopic dermatitis	0.00046	0.000989	CcSEcCtD
Lurasidone—Angiopathy—Betamethasone—atopic dermatitis	0.000458	0.000984	CcSEcCtD
Lurasidone—Angiopathy—Dexamethasone—atopic dermatitis	0.000458	0.000984	CcSEcCtD
Lurasidone—Convulsion—Prednisolone—atopic dermatitis	0.000456	0.000981	CcSEcCtD
Lurasidone—Hypertension—Prednisolone—atopic dermatitis	0.000454	0.000977	CcSEcCtD
Lurasidone—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000452	0.000971	CcSEcCtD
Lurasidone—Arrhythmia—Betamethasone—atopic dermatitis	0.000451	0.000969	CcSEcCtD
Lurasidone—Arrhythmia—Dexamethasone—atopic dermatitis	0.000451	0.000969	CcSEcCtD
Lurasidone—Bradycardia—Prednisone—atopic dermatitis	0.000447	0.000962	CcSEcCtD
Lurasidone—Convulsion—Hydrocortisone—atopic dermatitis	0.000445	0.000958	CcSEcCtD
Lurasidone—Dizziness—Tacrolimus—atopic dermatitis	0.000445	0.000956	CcSEcCtD
Lurasidone—Hypertension—Hydrocortisone—atopic dermatitis	0.000444	0.000954	CcSEcCtD
Lurasidone—Angioedema—Triamcinolone—atopic dermatitis	0.000442	0.000951	CcSEcCtD
Lurasidone—Angioedema—Methylprednisolone—atopic dermatitis	0.000441	0.000949	CcSEcCtD
Lurasidone—Myalgia—Hydrocortisone—atopic dermatitis	0.000438	0.000941	CcSEcCtD
Lurasidone—Malaise—Triamcinolone—atopic dermatitis	0.000436	0.000939	CcSEcCtD
Lurasidone—Anxiety—Hydrocortisone—atopic dermatitis	0.000436	0.000938	CcSEcCtD
Lurasidone—Malaise—Methylprednisolone—atopic dermatitis	0.000435	0.000936	CcSEcCtD
Lurasidone—Vertigo—Triamcinolone—atopic dermatitis	0.000435	0.000935	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000435	0.000935	CcSEcCtD
Lurasidone—Syncope—Triamcinolone—atopic dermatitis	0.000434	0.000933	CcSEcCtD
Lurasidone—Vertigo—Methylprednisolone—atopic dermatitis	0.000434	0.000933	CcSEcCtD
Lurasidone—Syncope—Methylprednisolone—atopic dermatitis	0.000433	0.000931	CcSEcCtD
Lurasidone—Connective tissue disorder—Prednisone—atopic dermatitis	0.000432	0.000928	CcSEcCtD
Lurasidone—Vomiting—Tacrolimus—atopic dermatitis	0.000428	0.000919	CcSEcCtD
Lurasidone—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000425	0.000915	CcSEcCtD
Lurasidone—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000424	0.000913	CcSEcCtD
Lurasidone—Rash—Tacrolimus—atopic dermatitis	0.000424	0.000912	CcSEcCtD
Lurasidone—Dermatitis—Tacrolimus—atopic dermatitis	0.000424	0.000911	CcSEcCtD
Lurasidone—Shock—Prednisolone—atopic dermatitis	0.000423	0.000909	CcSEcCtD
Lurasidone—Convulsion—Triamcinolone—atopic dermatitis	0.000419	0.000902	CcSEcCtD
Lurasidone—Tachycardia—Prednisolone—atopic dermatitis	0.000419	0.000901	CcSEcCtD
Lurasidone—Convulsion—Methylprednisolone—atopic dermatitis	0.000418	0.0009	CcSEcCtD
Lurasidone—Hypertension—Triamcinolone—atopic dermatitis	0.000418	0.000899	CcSEcCtD
Lurasidone—Hypertension—Methylprednisolone—atopic dermatitis	0.000417	0.000897	CcSEcCtD
Lurasidone—Infection—Hydrocortisone—atopic dermatitis	0.000417	0.000896	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000415	0.000893	CcSEcCtD
Lurasidone—Shock—Hydrocortisone—atopic dermatitis	0.000413	0.000887	CcSEcCtD
Lurasidone—Myalgia—Triamcinolone—atopic dermatitis	0.000412	0.000886	CcSEcCtD
Lurasidone—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000411	0.000885	CcSEcCtD
Lurasidone—Myalgia—Methylprednisolone—atopic dermatitis	0.000411	0.000884	CcSEcCtD
Lurasidone—Eye disorder—Prednisone—atopic dermatitis	0.000411	0.000883	CcSEcCtD
Lurasidone—Anxiety—Methylprednisolone—atopic dermatitis	0.00041	0.000881	CcSEcCtD
Lurasidone—Tachycardia—Hydrocortisone—atopic dermatitis	0.000409	0.00088	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000408	0.000878	CcSEcCtD
Lurasidone—Skin disorder—Hydrocortisone—atopic dermatitis	0.000407	0.000876	CcSEcCtD
Lurasidone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000405	0.000872	CcSEcCtD
Lurasidone—Dry mouth—Triamcinolone—atopic dermatitis	0.000403	0.000867	CcSEcCtD
Lurasidone—Angioedema—Dexamethasone—atopic dermatitis	0.000401	0.000863	CcSEcCtD
Lurasidone—Angioedema—Betamethasone—atopic dermatitis	0.000401	0.000863	CcSEcCtD
Lurasidone—Nausea—Tacrolimus—atopic dermatitis	0.000399	0.000859	CcSEcCtD
Lurasidone—Angiopathy—Prednisone—atopic dermatitis	0.000399	0.000857	CcSEcCtD
Lurasidone—Malaise—Betamethasone—atopic dermatitis	0.000396	0.000852	CcSEcCtD
Lurasidone—Malaise—Dexamethasone—atopic dermatitis	0.000396	0.000852	CcSEcCtD
Lurasidone—Vertigo—Dexamethasone—atopic dermatitis	0.000394	0.000848	CcSEcCtD
Lurasidone—Vertigo—Betamethasone—atopic dermatitis	0.000394	0.000848	CcSEcCtD
Lurasidone—Syncope—Betamethasone—atopic dermatitis	0.000394	0.000847	CcSEcCtD
Lurasidone—Syncope—Dexamethasone—atopic dermatitis	0.000394	0.000847	CcSEcCtD
Lurasidone—Arrhythmia—Prednisone—atopic dermatitis	0.000392	0.000844	CcSEcCtD
Lurasidone—Infection—Triamcinolone—atopic dermatitis	0.000392	0.000844	CcSEcCtD
Lurasidone—Hypotension—Hydrocortisone—atopic dermatitis	0.000392	0.000843	CcSEcCtD
Lurasidone—Infection—Methylprednisolone—atopic dermatitis	0.000391	0.000842	CcSEcCtD
Lurasidone—Shock—Triamcinolone—atopic dermatitis	0.000389	0.000836	CcSEcCtD
Lurasidone—Insomnia—Prednisolone—atopic dermatitis	0.000388	0.000835	CcSEcCtD
Lurasidone—Shock—Methylprednisolone—atopic dermatitis	0.000388	0.000834	CcSEcCtD
Lurasidone—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000386	0.000831	CcSEcCtD
Lurasidone—Loss of consciousness—Betamethasone—atopic dermatitis	0.000386	0.00083	CcSEcCtD
Lurasidone—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000386	0.00083	CcSEcCtD
Lurasidone—Tachycardia—Triamcinolone—atopic dermatitis	0.000385	0.000829	CcSEcCtD
Lurasidone—Mental disorder—Prednisone—atopic dermatitis	0.000385	0.000828	CcSEcCtD
Lurasidone—Tachycardia—Methylprednisolone—atopic dermatitis	0.000385	0.000827	CcSEcCtD
Lurasidone—Skin disorder—Methylprednisolone—atopic dermatitis	0.000383	0.000823	CcSEcCtD
Lurasidone—Malnutrition—Prednisone—atopic dermatitis	0.000382	0.000822	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000382	0.000822	CcSEcCtD
Lurasidone—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000382	0.000821	CcSEcCtD
Lurasidone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000381	0.000819	CcSEcCtD
Lurasidone—Convulsion—Betamethasone—atopic dermatitis	0.00038	0.000818	CcSEcCtD
Lurasidone—Convulsion—Dexamethasone—atopic dermatitis	0.00038	0.000818	CcSEcCtD
Lurasidone—Insomnia—Hydrocortisone—atopic dermatitis	0.000379	0.000816	CcSEcCtD
Lurasidone—Hypertension—Dexamethasone—atopic dermatitis	0.000379	0.000815	CcSEcCtD
Lurasidone—Hypertension—Betamethasone—atopic dermatitis	0.000379	0.000815	CcSEcCtD
Lurasidone—Myalgia—Dexamethasone—atopic dermatitis	0.000374	0.000804	CcSEcCtD
Lurasidone—Myalgia—Betamethasone—atopic dermatitis	0.000374	0.000804	CcSEcCtD
Lurasidone—Anxiety—Dexamethasone—atopic dermatitis	0.000373	0.000801	CcSEcCtD
Lurasidone—Anxiety—Betamethasone—atopic dermatitis	0.000373	0.000801	CcSEcCtD
Lurasidone—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000369	0.000794	CcSEcCtD
Lurasidone—Hypotension—Methylprednisolone—atopic dermatitis	0.000368	0.000792	CcSEcCtD
Lurasidone—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000365	0.000784	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000362	0.000779	CcSEcCtD
Lurasidone—Fatigue—Hydrocortisone—atopic dermatitis	0.000362	0.000778	CcSEcCtD
Lurasidone—Vision blurred—Prednisone—atopic dermatitis	0.00036	0.000775	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00036	0.000774	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000359	0.000772	CcSEcCtD
Lurasidone—Insomnia—Triamcinolone—atopic dermatitis	0.000357	0.000768	CcSEcCtD
Lurasidone—Insomnia—Methylprednisolone—atopic dermatitis	0.000356	0.000767	CcSEcCtD
Lurasidone—Infection—Dexamethasone—atopic dermatitis	0.000356	0.000766	CcSEcCtD
Lurasidone—Infection—Betamethasone—atopic dermatitis	0.000356	0.000766	CcSEcCtD
Lurasidone—Anaemia—Prednisone—atopic dermatitis	0.000353	0.00076	CcSEcCtD
Lurasidone—Shock—Dexamethasone—atopic dermatitis	0.000353	0.000758	CcSEcCtD
Lurasidone—Shock—Betamethasone—atopic dermatitis	0.000353	0.000758	CcSEcCtD
Lurasidone—Dyspnoea—Triamcinolone—atopic dermatitis	0.000352	0.000757	CcSEcCtD
Lurasidone—Nervous system disorder—Betamethasone—atopic dermatitis	0.000351	0.000756	CcSEcCtD
Lurasidone—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000351	0.000756	CcSEcCtD
Lurasidone—Agitation—Prednisone—atopic dermatitis	0.000351	0.000756	CcSEcCtD
Lurasidone—Tachycardia—Dexamethasone—atopic dermatitis	0.00035	0.000752	CcSEcCtD
Lurasidone—Tachycardia—Betamethasone—atopic dermatitis	0.00035	0.000752	CcSEcCtD
Lurasidone—Angioedema—Prednisone—atopic dermatitis	0.000349	0.000751	CcSEcCtD
Lurasidone—Dyspepsia—Triamcinolone—atopic dermatitis	0.000348	0.000748	CcSEcCtD
Lurasidone—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000347	0.000746	CcSEcCtD
Lurasidone—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000346	0.000745	CcSEcCtD
Lurasidone—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000346	0.000745	CcSEcCtD
Lurasidone—Malaise—Prednisone—atopic dermatitis	0.000345	0.000742	CcSEcCtD
Lurasidone—Vertigo—Prednisone—atopic dermatitis	0.000344	0.000739	CcSEcCtD
Lurasidone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000343	0.000738	CcSEcCtD
Lurasidone—Syncope—Prednisone—atopic dermatitis	0.000343	0.000737	CcSEcCtD
Lurasidone—Fatigue—Triamcinolone—atopic dermatitis	0.000341	0.000732	CcSEcCtD
Lurasidone—Fatigue—Methylprednisolone—atopic dermatitis	0.00034	0.000731	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisone—atopic dermatitis	0.000336	0.000723	CcSEcCtD
Lurasidone—Hypotension—Betamethasone—atopic dermatitis	0.000335	0.00072	CcSEcCtD
Lurasidone—Hypotension—Dexamethasone—atopic dermatitis	0.000335	0.00072	CcSEcCtD
Lurasidone—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000332	0.000713	CcSEcCtD
Lurasidone—Convulsion—Prednisone—atopic dermatitis	0.000331	0.000713	CcSEcCtD
Lurasidone—Hypertension—Prednisone—atopic dermatitis	0.00033	0.00071	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000326	0.000702	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000326	0.000702	CcSEcCtD
Lurasidone—Myalgia—Prednisone—atopic dermatitis	0.000326	0.0007	CcSEcCtD
Lurasidone—Anxiety—Prednisone—atopic dermatitis	0.000324	0.000698	CcSEcCtD
Lurasidone—Insomnia—Dexamethasone—atopic dermatitis	0.000324	0.000697	CcSEcCtD
Lurasidone—Insomnia—Betamethasone—atopic dermatitis	0.000324	0.000697	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000323	0.000695	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000322	0.000693	CcSEcCtD
Lurasidone—Dyspepsia—Betamethasone—atopic dermatitis	0.000315	0.000678	CcSEcCtD
Lurasidone—Dyspepsia—Dexamethasone—atopic dermatitis	0.000315	0.000678	CcSEcCtD
Lurasidone—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000312	0.00067	CcSEcCtD
Lurasidone—Decreased appetite—Betamethasone—atopic dermatitis	0.000312	0.00067	CcSEcCtD
Lurasidone—Decreased appetite—Dexamethasone—atopic dermatitis	0.000312	0.00067	CcSEcCtD
Lurasidone—Infection—Prednisone—atopic dermatitis	0.00031	0.000667	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000309	0.000665	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000309	0.000665	CcSEcCtD
Lurasidone—Fatigue—Dexamethasone—atopic dermatitis	0.000309	0.000664	CcSEcCtD
Lurasidone—Fatigue—Betamethasone—atopic dermatitis	0.000309	0.000664	CcSEcCtD
Lurasidone—Shock—Prednisone—atopic dermatitis	0.000307	0.00066	CcSEcCtD
Lurasidone—Nervous system disorder—Prednisone—atopic dermatitis	0.000306	0.000658	CcSEcCtD
Lurasidone—Tachycardia—Prednisone—atopic dermatitis	0.000305	0.000655	CcSEcCtD
Lurasidone—Skin disorder—Prednisone—atopic dermatitis	0.000303	0.000652	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisone—atopic dermatitis	0.000302	0.000649	CcSEcCtD
Lurasidone—Asthenia—Hydrocortisone—atopic dermatitis	0.000301	0.000647	CcSEcCtD
Lurasidone—Pruritus—Hydrocortisone—atopic dermatitis	0.000297	0.000638	CcSEcCtD
Lurasidone—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000293	0.00063	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000293	0.00063	CcSEcCtD
Lurasidone—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000287	0.000617	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000284	0.000611	CcSEcCtD
Lurasidone—Dizziness—Prednisolone—atopic dermatitis	0.000284	0.000611	CcSEcCtD
Lurasidone—Asthenia—Triamcinolone—atopic dermatitis	0.000283	0.000609	CcSEcCtD
Lurasidone—Abdominal pain—Betamethasone—atopic dermatitis	0.000283	0.000609	CcSEcCtD
Lurasidone—Abdominal pain—Dexamethasone—atopic dermatitis	0.000283	0.000609	CcSEcCtD
Lurasidone—Asthenia—Methylprednisolone—atopic dermatitis	0.000283	0.000608	CcSEcCtD
Lurasidone—Insomnia—Prednisone—atopic dermatitis	0.000282	0.000607	CcSEcCtD
Lurasidone—Pruritus—Triamcinolone—atopic dermatitis	0.000279	0.000601	CcSEcCtD
Lurasidone—Pruritus—Methylprednisolone—atopic dermatitis	0.000279	0.0006	CcSEcCtD
Lurasidone—Dizziness—Hydrocortisone—atopic dermatitis	0.000277	0.000597	CcSEcCtD
Lurasidone—Dyspepsia—Prednisone—atopic dermatitis	0.000275	0.000591	CcSEcCtD
Lurasidone—Decreased appetite—Prednisone—atopic dermatitis	0.000271	0.000583	CcSEcCtD
Lurasidone—Rash—Prednisolone—atopic dermatitis	0.000271	0.000582	CcSEcCtD
Lurasidone—Dermatitis—Prednisolone—atopic dermatitis	0.000271	0.000582	CcSEcCtD
Lurasidone—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00027	0.00058	CcSEcCtD
Lurasidone—Fatigue—Prednisone—atopic dermatitis	0.000269	0.000579	CcSEcCtD
Lurasidone—Vomiting—Hydrocortisone—atopic dermatitis	0.000267	0.000574	CcSEcCtD
Lurasidone—Rash—Hydrocortisone—atopic dermatitis	0.000264	0.000569	CcSEcCtD
Lurasidone—Dermatitis—Hydrocortisone—atopic dermatitis	0.000264	0.000568	CcSEcCtD
Lurasidone—Dizziness—Triamcinolone—atopic dermatitis	0.000261	0.000562	CcSEcCtD
Lurasidone—Dizziness—Methylprednisolone—atopic dermatitis	0.000261	0.00056	CcSEcCtD
Lurasidone—Asthenia—Dexamethasone—atopic dermatitis	0.000257	0.000553	CcSEcCtD
Lurasidone—Asthenia—Betamethasone—atopic dermatitis	0.000257	0.000553	CcSEcCtD
Lurasidone—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000255	0.000549	CcSEcCtD
Lurasidone—Nausea—Prednisolone—atopic dermatitis	0.000255	0.000549	CcSEcCtD
Lurasidone—Pruritus—Dexamethasone—atopic dermatitis	0.000254	0.000545	CcSEcCtD
Lurasidone—Pruritus—Betamethasone—atopic dermatitis	0.000254	0.000545	CcSEcCtD
Lurasidone—Vomiting—Triamcinolone—atopic dermatitis	0.000251	0.00054	CcSEcCtD
Lurasidone—Vomiting—Methylprednisolone—atopic dermatitis	0.000251	0.000539	CcSEcCtD
Lurasidone—Nausea—Hydrocortisone—atopic dermatitis	0.000249	0.000536	CcSEcCtD
Lurasidone—Rash—Triamcinolone—atopic dermatitis	0.000249	0.000536	CcSEcCtD
Lurasidone—Dermatitis—Triamcinolone—atopic dermatitis	0.000249	0.000535	CcSEcCtD
Lurasidone—Rash—Methylprednisolone—atopic dermatitis	0.000248	0.000534	CcSEcCtD
Lurasidone—Dermatitis—Methylprednisolone—atopic dermatitis	0.000248	0.000534	CcSEcCtD
Lurasidone—Abdominal pain—Prednisone—atopic dermatitis	0.000247	0.000531	CcSEcCtD
Lurasidone—Diarrhoea—Betamethasone—atopic dermatitis	0.000245	0.000527	CcSEcCtD
Lurasidone—Diarrhoea—Dexamethasone—atopic dermatitis	0.000245	0.000527	CcSEcCtD
Lurasidone—Dizziness—Betamethasone—atopic dermatitis	0.000237	0.00051	CcSEcCtD
Lurasidone—Dizziness—Dexamethasone—atopic dermatitis	0.000237	0.00051	CcSEcCtD
Lurasidone—Nausea—Triamcinolone—atopic dermatitis	0.000235	0.000505	CcSEcCtD
Lurasidone—Nausea—Methylprednisolone—atopic dermatitis	0.000234	0.000503	CcSEcCtD
Lurasidone—Vomiting—Dexamethasone—atopic dermatitis	0.000228	0.00049	CcSEcCtD
Lurasidone—Vomiting—Betamethasone—atopic dermatitis	0.000228	0.00049	CcSEcCtD
Lurasidone—Rash—Betamethasone—atopic dermatitis	0.000226	0.000486	CcSEcCtD
Lurasidone—Rash—Dexamethasone—atopic dermatitis	0.000226	0.000486	CcSEcCtD
Lurasidone—Dermatitis—Dexamethasone—atopic dermatitis	0.000226	0.000485	CcSEcCtD
Lurasidone—Dermatitis—Betamethasone—atopic dermatitis	0.000226	0.000485	CcSEcCtD
Lurasidone—Asthenia—Prednisone—atopic dermatitis	0.000224	0.000482	CcSEcCtD
Lurasidone—Pruritus—Prednisone—atopic dermatitis	0.000221	0.000475	CcSEcCtD
Lurasidone—Diarrhoea—Prednisone—atopic dermatitis	0.000214	0.000459	CcSEcCtD
Lurasidone—Nausea—Betamethasone—atopic dermatitis	0.000213	0.000458	CcSEcCtD
Lurasidone—Nausea—Dexamethasone—atopic dermatitis	0.000213	0.000458	CcSEcCtD
Lurasidone—Dizziness—Prednisone—atopic dermatitis	0.000206	0.000444	CcSEcCtD
Lurasidone—Vomiting—Prednisone—atopic dermatitis	0.000198	0.000427	CcSEcCtD
Lurasidone—Rash—Prednisone—atopic dermatitis	0.000197	0.000423	CcSEcCtD
Lurasidone—Dermatitis—Prednisone—atopic dermatitis	0.000197	0.000423	CcSEcCtD
Lurasidone—Nausea—Prednisone—atopic dermatitis	0.000185	0.000399	CcSEcCtD
Lurasidone—DRD2—G alpha (i) signalling events—CXCL8—atopic dermatitis	8.54e-05	0.0012	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—MAPK8—atopic dermatitis	8.51e-05	0.0012	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	8.5e-05	0.0012	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CXCR3—atopic dermatitis	8.5e-05	0.0012	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—CCR5—atopic dermatitis	8.41e-05	0.00119	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—STAT6—atopic dermatitis	8.39e-05	0.00118	CbGpPWpGaD
Lurasidone—HTR7—Circadian rythm related genes—IL6—atopic dermatitis	8.35e-05	0.00118	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	8.32e-05	0.00117	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—CCL5—atopic dermatitis	8.24e-05	0.00116	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	8.2e-05	0.00116	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GLB1—atopic dermatitis	8.2e-05	0.00115	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	8.13e-05	0.00115	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	8.13e-05	0.00115	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	8.12e-05	0.00114	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	8.06e-05	0.00114	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—IL5—atopic dermatitis	8.05e-05	0.00113	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL27—atopic dermatitis	8.03e-05	0.00113	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CCR3—atopic dermatitis	8.01e-05	0.00113	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	7.97e-05	0.00112	CbGpPWpGaD
Lurasidone—HTR7—GPCR ligand binding—CXCL8—atopic dermatitis	7.95e-05	0.00112	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL17—atopic dermatitis	7.94e-05	0.00112	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL27—atopic dermatitis	7.9e-05	0.00111	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	7.9e-05	0.00111	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CCR3—atopic dermatitis	7.88e-05	0.00111	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—NPS—atopic dermatitis	7.87e-05	0.00111	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—TAC1—atopic dermatitis	7.87e-05	0.00111	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—TAC1—atopic dermatitis	7.86e-05	0.00111	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—NPS—atopic dermatitis	7.86e-05	0.00111	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ADSL—atopic dermatitis	7.86e-05	0.00111	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—NPS—atopic dermatitis	7.73e-05	0.00109	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—TAC1—atopic dermatitis	7.73e-05	0.00109	CbGpPWpGaD
Lurasidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.73e-05	0.00109	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CXCR3—atopic dermatitis	7.72e-05	0.00109	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CXCR3—atopic dermatitis	7.71e-05	0.00109	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	7.67e-05	0.00108	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	7.65e-05	0.00108	CbGpPWpGaD
Lurasidone—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	7.64e-05	0.00108	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CXCR3—atopic dermatitis	7.59e-05	0.00107	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	7.58e-05	0.00107	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	7.56e-05	0.00106	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—CCL5—atopic dermatitis	7.49e-05	0.00105	CbGpPWpGaD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.48e-05	0.00105	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—CCR5—atopic dermatitis	7.43e-05	0.00105	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL5—atopic dermatitis	7.31e-05	0.00103	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	7.31e-05	0.00103	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—IL5—atopic dermatitis	7.31e-05	0.00103	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCR3—atopic dermatitis	7.27e-05	0.00102	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL17—atopic dermatitis	7.2e-05	0.00101	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—IL5—atopic dermatitis	7.19e-05	0.00101	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	7.19e-05	0.00101	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	7.17e-05	0.00101	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—TAC1—atopic dermatitis	7.14e-05	0.00101	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—NPS—atopic dermatitis	7.14e-05	0.00101	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	7.1e-05	0.001	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL17—atopic dermatitis	7.08e-05	0.000998	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—KIF3A—atopic dermatitis	7.07e-05	0.000996	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	7.04e-05	0.000991	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	7.04e-05	0.000991	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—NPS—atopic dermatitis	7.02e-05	0.000989	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—TAC1—atopic dermatitis	7.02e-05	0.000989	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	7e-05	0.000986	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	6.9e-05	0.000972	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CXCR3—atopic dermatitis	6.89e-05	0.00097	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CXCL10—atopic dermatitis	6.87e-05	0.000967	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.79e-05	0.000956	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—CCR5—atopic dermatitis	6.74e-05	0.00095	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.68e-05	0.000941	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL5—atopic dermatitis	6.64e-05	0.000935	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	6.61e-05	0.000931	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	6.61e-05	0.000931	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	6.55e-05	0.000923	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	6.54e-05	0.000922	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	6.53e-05	0.00092	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TAC1—atopic dermatitis	6.48e-05	0.000913	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NPS—atopic dermatitis	6.48e-05	0.000913	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	6.45e-05	0.000908	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	6.45e-05	0.000908	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	6.42e-05	0.000904	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL11—atopic dermatitis	6.4e-05	0.000901	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CMA1—atopic dermatitis	6.4e-05	0.000901	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	6.39e-05	0.0009	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	6.39e-05	0.0009	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCR3—atopic dermatitis	6.36e-05	0.000895	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	6.31e-05	0.000889	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	6.27e-05	0.000883	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CXCL10—atopic dermatitis	6.24e-05	0.000878	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	6.23e-05	0.000878	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	6.22e-05	0.000875	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	6.13e-05	0.000864	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	6.11e-05	0.000861	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.08e-05	0.000856	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL5—atopic dermatitis	6.03e-05	0.000849	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—STAT6—atopic dermatitis	6.01e-05	0.000847	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	5.94e-05	0.000837	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CCL5—atopic dermatitis	5.91e-05	0.000833	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	5.89e-05	0.000829	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CMA1—atopic dermatitis	5.8e-05	0.000818	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL11—atopic dermatitis	5.8e-05	0.000818	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	5.75e-05	0.000809	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	5.71e-05	0.000804	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	5.71e-05	0.000804	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—CXCL8—atopic dermatitis	5.7e-05	0.000803	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	5.66e-05	0.000797	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	5.58e-05	0.000786	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	5.57e-05	0.000784	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	5.55e-05	0.000781	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	5.5e-05	0.000775	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—STAT6—atopic dermatitis	5.46e-05	0.000769	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	5.44e-05	0.000766	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	5.39e-05	0.000759	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	5.37e-05	0.000756	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CCL5—atopic dermatitis	5.37e-05	0.000756	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	5.36e-05	0.000756	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CCR5—atopic dermatitis	5.33e-05	0.00075	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	5.28e-05	0.000743	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCR3—atopic dermatitis	5.21e-05	0.000734	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	5.2e-05	0.000732	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	5.2e-05	0.000732	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	5.17e-05	0.000728	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCL10—atopic dermatitis	5.14e-05	0.000724	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	5.09e-05	0.000717	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	5.07e-05	0.000714	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	5.07e-05	0.000714	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	5e-05	0.000704	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	4.88e-05	0.000688	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	4.87e-05	0.000686	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—IL2—atopic dermatitis	4.87e-05	0.000686	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CCR5—atopic dermatitis	4.84e-05	0.000681	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	4.83e-05	0.000681	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	4.8e-05	0.000677	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NPS—atopic dermatitis	4.8e-05	0.000677	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	4.8e-05	0.000676	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	4.79e-05	0.000675	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	4.75e-05	0.00067	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR3—atopic dermatitis	4.73e-05	0.000666	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	4.71e-05	0.000663	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	4.66e-05	0.000656	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TAC1—atopic dermatitis	4.65e-05	0.000655	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	4.65e-05	0.000655	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	4.63e-05	0.000652	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	4.56e-05	0.000642	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—CXCL8—atopic dermatitis	4.49e-05	0.000633	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL5—atopic dermatitis	4.47e-05	0.000629	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCL5—atopic dermatitis	4.42e-05	0.000623	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	4.39e-05	0.000618	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	4.36e-05	0.000614	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	4.33e-05	0.000609	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	4.32e-05	0.000609	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	4.32e-05	0.000608	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	4.29e-05	0.000604	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	4.24e-05	0.000597	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TAC1—atopic dermatitis	4.22e-05	0.000594	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NPS—atopic dermatitis	4.22e-05	0.000594	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	4.15e-05	0.000584	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NPS—atopic dermatitis	4.15e-05	0.000584	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	4.14e-05	0.000583	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NGF—atopic dermatitis	4.1e-05	0.000577	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	4.08e-05	0.000574	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	4.07e-05	0.000573	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCR5—atopic dermatitis	3.98e-05	0.000561	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—IL2—atopic dermatitis	3.96e-05	0.000557	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	3.93e-05	0.000553	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL5—atopic dermatitis	3.92e-05	0.000552	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL2—atopic dermatitis	3.9e-05	0.000549	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL5—atopic dermatitis	3.86e-05	0.000543	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	3.81e-05	0.000536	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	3.78e-05	0.000532	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	3.78e-05	0.000532	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	3.7e-05	0.000521	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	3.68e-05	0.000519	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	3.51e-05	0.000494	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.49e-05	0.000492	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	3.38e-05	0.000476	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.35e-05	0.000472	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	3.34e-05	0.000471	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.33e-05	0.000469	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	3.29e-05	0.000463	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	3.28e-05	0.000462	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PPARA—atopic dermatitis	3.28e-05	0.000461	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.22e-05	0.000454	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	3.18e-05	0.000448	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	3.17e-05	0.000447	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	3.08e-05	0.000433	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NGF—atopic dermatitis	3.04e-05	0.000428	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	3.02e-05	0.000426	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	2.99e-05	0.000421	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	2.95e-05	0.000416	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	2.94e-05	0.000414	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	2.92e-05	0.000412	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	2.92e-05	0.000412	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	2.89e-05	0.000407	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL5—atopic dermatitis	2.88e-05	0.000405	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.87e-05	0.000405	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	2.86e-05	0.000402	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	2.83e-05	0.000399	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	2.79e-05	0.000394	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	2.79e-05	0.000393	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	2.75e-05	0.000387	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGF—atopic dermatitis	2.66e-05	0.000375	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARA—atopic dermatitis	2.66e-05	0.000375	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	2.65e-05	0.000374	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGF—atopic dermatitis	2.62e-05	0.000369	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.62e-05	0.000368	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.61e-05	0.000368	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR5—atopic dermatitis	2.59e-05	0.000365	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	2.58e-05	0.000363	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	2.55e-05	0.000359	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL2—atopic dermatitis	2.54e-05	0.000357	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.5e-05	0.000353	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	2.5e-05	0.000352	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	2.49e-05	0.000351	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.42e-05	0.000341	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	2.41e-05	0.000339	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	2.39e-05	0.000336	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.38e-05	0.000335	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	2.32e-05	0.000327	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL2—atopic dermatitis	2.3e-05	0.000324	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—atopic dermatitis	2.29e-05	0.000323	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	2.27e-05	0.00032	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	2.2e-05	0.00031	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.16e-05	0.000305	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	2.12e-05	0.000298	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	1.97e-05	0.000277	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	1.79e-05	0.000251	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	1.73e-05	0.000243	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL2—atopic dermatitis	1.71e-05	0.00024	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	1.7e-05	0.000239	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	1.65e-05	0.000233	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	1.64e-05	0.000231	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	1.57e-05	0.000221	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	1.57e-05	0.000221	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	1.54e-05	0.000217	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	1.52e-05	0.000214	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL2—atopic dermatitis	1.5e-05	0.000211	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—atopic dermatitis	1.49e-05	0.00021	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL2—atopic dermatitis	1.47e-05	0.000208	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	1.47e-05	0.000207	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	1.4e-05	0.000198	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	1.38e-05	0.000194	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	1.36e-05	0.000191	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—atopic dermatitis	1.35e-05	0.000191	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	1.34e-05	0.000189	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	1.33e-05	0.000188	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.23e-05	0.000174	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.13e-05	0.00016	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1e-05	0.000141	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	9.7e-06	0.000137	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—atopic dermatitis	8.8e-06	0.000124	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—atopic dermatitis	8.66e-06	0.000122	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	7.88e-06	0.000111	CbGpPWpGaD
